| PERIOD ENDING | 31-Oct-08 | 31-Oct-07 | 31-Oct-06 | | Total Revenue | 31,013,482 | 43,281,475 | 32,162,954 | | Cost of Revenue | 10,061,961 | 14,428,206 | 9,554,748 | | | Gross Profit | 20,951,522 | 28,853,269 | 22,608,205 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 11,102,254 | 12,968,621 | 12,427,954 | | Non Recurring |
-
|
-
|
-
| | Others | 2,313,970 | 3,066,911 | 450,612 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,535,298 | 12,817,737 | 9,729,639 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (48,199) | (6,246) | | Earnings Before Interest And Taxes | 8,136,136 | 12,678,380 | 9,729,639 | | Interest Expense | 3,166,398 | 5,317,585 | 4,193,810 | | Income Before Tax | 4,969,738 | 7,360,795 | 5,535,829 | | Income Tax Expense | 849,945 | 1,389,383 | 1,251,897 | | Minority Interest | (146,485) | (256,711) | (39,261) | | | | Net Income From Continuing Ops | 3,372,470 | 5,805,860 | 4,238,425 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (25,877) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,372,470 | 5,805,860 | 4,212,548 | | Preferred Stock And Other Adjustments | (83,588) | (92,206) | (53,538) | | | Net Income Applicable To Common Shares | $3,288,882 | $5,713,653 | $4,159,010 |
|
0.29% Nasdaq 
Income Statement
